Grainne O’Kane/X
Jan 26, 2025, 05:56
Grainne O’Kane: CheckMate 9DW expanded analyses in HCC
Grainne O’Kane, Medical Oncologist at Princess Margaret Cancer Centre and Director of the Cancer Clinical Trials Unit at Trinity St James’s Cancer Institute, shared a post on X:
“CheckMate 9DW expanded analyses
– esponse in HCC predicts OS
– at 24 weeks med OS not reached in responders ipi/nivo
– responses consistent across subgroups
– still some toxicity concerns particularly in poor liver function.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 13, 2025, 21:09
Aug 13, 2025, 20:52
Aug 13, 2025, 20:36
Aug 13, 2025, 20:15
Aug 13, 2025, 19:46
Aug 13, 2025, 19:37
Aug 13, 2025, 19:21
Aug 13, 2025, 19:12